Avatrial
PrivateLast Round
Grant
Nov 29, 2024
Total Funding Raised
$95,000
Company Overview
Avatrial is a biotechnology company that offers integrated, end-to-end services for cancer drug discovery, using human tissue, multi-omic data generation, and machine learning for biomarker identification.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avatrial Comparables
Compare Avatrial with similar companies based on industry and business-model similarity.
Avatrial Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 29, 2024 | ||||
| Accelerator | Jul 2, 2024 |
Avatrial Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Quantum Computing Centre | Grant |
Avatrial Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avatrial's valuation, stock price, and market status.